Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Bioorg Med Chem Lett. 2020 Mar 30;30(11):127163. doi: 10.1016/j.bmcl.2020.127163

Scheme 2:

Scheme 2:

Reagents and conditions: (i) Savinase, 1,4-butanediol, pH 8, 27%; (ii) CBZThr (O-tBu)-Dap(BOC)OH, HATU, NEtiPr2, DCM, quant.; (iii) PhB(OH)2, Pd(OAc)2, X-Phos, K3PO4,toluene, 100°C, 50%; (iv) NH3+HCOO-, 10% Pd/C, MeOH; 93%; (v) RCO2H (N-BOC protected), HATU, NEtiPr2, DCM, DMF; (vi) TFA, DCM, followed by prep HPLC, 23% over 2 steps.